Govt reviewing pharma industry's proposal on trade margin rationalization on non-scheduled drugs
The central government is reviewing a proposal from the pharmaceutical industry regarding trade margin rationalization on non-scheduled drugs.
The National Pharmaceutical Pricing Authority (NPPA) under Department of Pharmaceuticals (DoP) that fixes the ceiling price of scheduled medicines as per provisions of the Drugs (Prices Control) Order, 2013 on Tuesday convened a meeting with the representatives of drug associations that have long been proposing "one molecule-one MRP" formula on non-scheduled drugs instead of capping trade margins.
Union Health Minister Mansukh Mandaviya, S Aparna, Secretary at Department of Pharmaceuticals (DoP) and Kamlesh Pant, NPPA Chairman, discussed the proposal with the representatives in a five-hour long meeting
